Oviva Diabetes Support: Evaluating clinical outcomes for people with type 2 diabetes following completion of a remote programme of structured education and behaviour change

Oviva糖尿病支持是一项以患者为中心的数字支持计划，为2型糖尿病患者提供结构化教育和行为改变。该计划由营养师一对一授课，在10-12周内提供个性化护理，以支持完成已定义的课程，并帮助参与者学习如何管理自己的状况。由于完全远程(通过电话和Oviva智能手机应用程序提供)，课程高度可访问，课程通过基于网络的Oviva学习平台提供，该平台包括引人入胜的多种格式内容，如视频、播客和食谱。除了个人营养师的指导外，参与者还可以使用Oviva应用程序自我监控食物摄入量、活动水平和体重。基于有效和可获得的结构化教育提供方法的证据，Oviva糖尿病支持旨在让参与者具备自我管理技能，并通过引导行为改变和自我指导学习帮助他们养成长期健康的习惯。Oviva糖尿病支持已在13个领域向NHS参与者提供，并显示出C.90%的接受率，而全国平均水平为7.6%。现实世界的数据还表明，参与者的健康和临床结果的改善是优越的，而且实现的成本比传统模式更低。该项目将使300名参与者能够获得Oviva糖尿病支持。伦敦国王学院将在该计划完成后对该计划对临床结果的影响进行独立评估，该评估将用于进一步分析NHS节省成本的潜力。此外，评估结果将被用来为未来一项更大规模的临床试验提供参考，该试验将寻求提供更多临床有效性的证据。

"Oviva Diabetes Support is a patient-centred, digitally enabled programme of structured education and behaviour change for people with type 2 diabetes. Delivered 1-to-1 by dietitians, the programme provides individualised care over 10-12 weeks to support completion of a defined curriculum and help the participant learn to manage their condition.It is highly accessible as it is fully remote (delivered via phone calls and the Oviva smartphone app) and the curriculum is delivered via a web-based Oviva Learning Platform, comprised of engaging, multi-format content, such as videos, podcasts and recipes. Participants can also use the Oviva app for self-monitoring of food intake, activity levels and weight, in addition to coaching from their personal dietitian.Building on evidence of effective and accessible approaches to structured education provision, Oviva Diabetes Support aims to equip participants with self-management skills and help them adopt long-term healthier habits through guided behaviour change and self-directed learning.Oviva Diabetes Support has been made available to participants in the NHS in 13 areas and has demonstrated uptake of c.90%, in comparison with the national average of 7.6%, indicating that the innovative service model is far more accessible for users than traditional models.Real-world data also indicates that improvements in health and clinical outcomes for participants are superior and are achieved at lower cost to traditional models.This project will enable 300 participants to access Oviva Diabetes Support. An independent evaluation of the programme's impact on clinical outcomes following completion of the programme will be carried out by King's College London, which will be used to further analyse the potential for NHS cost-savings. In addition, the findings of the evaluation will be used to inform a larger clinical trial in future, which will seek to provide further evidence of clinical effectiveness."